CD98 expression modulates intestinal homeostasis, inflammation, and colitis-associated cancer in mice

Journal of Clinical Investigation

Volumn 121, Issue 5, 2011, Pages 1733-1747

  Nguyen, Hang Thi Thu ^a   Dalmasso, Guillaume ^a   Torkvist, Leif ^b   Halfvarson, Jonas ^c   Yan, Yutao ^a   Laroui, Hamed ^a   Shmerling, Doron ^d   Tallone, Tiziano ^d   D'Amato, Mauro ^b   Sitaraman, Shanthi V ^a   Merlin, Didier ^a,e  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b KAROLINSKA INSTITUTE   (Sweden)

^c ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

^d POLYGENE AG   (Switzerland)

^e ATLANTA VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD98 ANTIGEN;

ALLELE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; COLITIS; COLON CANCER; COLON CARCINOGENESIS; CONTROLLED STUDY; GENETIC ASSOCIATION; HOMEOSTASIS; INNATE IMMUNITY; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIGENS, CD98; ANTIGENS, CD98 HEAVY CHAIN; CELL MEMBRANE; CELL PROLIFERATION; CELL SURVIVAL; COLITIS; GENE EXPRESSION REGULATION; HOMEOSTASIS; INFLAMMATION; INTESTINES; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NEOPLASMS; POLYMORPHISM, GENETIC;

EID: 79955485553     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI44631     Document Type: Article

References (40)

1. Weir HK, et al. Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control. J Natl Cancer Inst. 2003;95(17):1276-1299.
2. Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002;420(6917):860-867. (Pubitemid 36019639)
3. Karin M, Lawrence T, Nizet V. Innate immunity gone awry: linking microbial infections to chronic inflammation and cancer. Cell. 2006;124(4):823-835. (Pubitemid 43261455)
4. Terzic J, Grivennikov S, Karin E, Karin M. Inflammation and colon cancer. Gastroenterology. 2010; 138(6):2101-2114.e5.
5. Yan Y, Vasudevan S, Nguyen HT, Merlin D. Intestinal epithelial CD98: an oligomeric and multifunctional protein. Biochim Biophys Acta. 2008;1780(10):1087-1092.
6. Deves R, Boyd CA. Surface antigen CD98(4F2): not a single membrane protein, but a family of proteins with multiple functions. J Membr Biol. 2000;173(3):165-177. (Pubitemid 30100209)
7. Kehrl JH, Fauci AS. Identification, purification, and characterization of antigen-activated and antigen-specific human B lymphocytes. J Exp Med. 1983;157(5):1692-1697. (Pubitemid 13089008)
8. Fenczik CA, Sethi T, Ramos JW, Hughes PE, Ginsberg MH. Complementation of dominant suppression implicates CD98 in integrin activation. Nature. 1997;390(6655):81-85. (Pubitemid 27494760)
9. Feral CC, Nishiya N, Fenczik CA, Stuhlmann H, Slepak M, Ginsberg MH. CD98hc (SLC3A2) mediates integrin signaling. Proc Natl Acad Sci U S A. 2005;102(2):355-360. (Pubitemid 40116771)
10. Merlin D, et al. CD98-mediated links between amino acid transport and beta 1 integrin distribution in polarized columnar epithelia. J Biol Chem. 2001;276(42):39282-39289.
11. Dixon WT, Sikora LK, Demetrick DJ, Jerry LM. Isolation and characterization of a heterodimeric surface antigen on human melanoma cells and evidence that it is the 4F2 cell activation/proliferation molecule. Int J Cancer. 1990;45(1):59-68. (Pubitemid 20032099)
12. Esteban F, Ruiz-Cabello F, Concha A, Perez Ayala M, Delgado M, Garrido F. Relationship of 4F2 antigen with local growth and metastatic potential of squamous cell carcinoma of the larynx. Cancer. 1990;66(7):1493-1498. (Pubitemid 20355415)
13. Garber ME, et al. Diversity of gene expression in adenocarcinoma of the lung. Proc Natl Acad Sci U S A. 2001;98(24):13784-13789. (Pubitemid 33115976)
14. Esseghir S, et al. Identification of transmembrane proteins as potential prognostic markers and therapeutic targets in breast cancer by a screen for signal sequence encoding transcripts. J Pathol. 2006;210(4):420-430. (Pubitemid 44830602)
15. Prager GW, et al. CD98hc (SLC3A2), a novel marker in renal cell cancer. Eur J Clin Invest. 2009;39(4):304-310.
16. Kaira K, et al. l-type amino acid transporter 1 and CD98 expression in primary and metastatic sites of human neoplasms. Cancer Sci. 2008; 99(12):2380-2386.
17. Kucharzik T, et al. Activation of epithelial CD98 glycoprotein perpetuates colonic inflammation. Lab Invest. 2005;85(7):932-941. (Pubitemid 41021301)
18. Fais S, Pallone F. Ability of human colonic epithelium to express the 4F2 antigen, the common acute lymphoblastic leukemia antigen, and the transferrin receptor. Studies in inflammatory bowel disease and after in vitro exposure to different stimuli. Gastroenterology. 1989;97(6):1435-1441. (Pubitemid 20004168)
19. Yan Y, Dalmasso G, Sitaraman S, Merlin D. Characterization of the human intestinal CD98 promoter and its regulation by interferon-gamma. Am J Physiol Gastrointest Liver Physiol. 2007;292(2):G535-G545.
20. Schreiber S, MacDermott RP, Raedler A, Pinnau R, Bertovich MJ, Nash GS. Increased activation of isolated intestinal lamina propria mononuclear cells in inflammatory bowel disease. Gastroenterology. 1991;101(4):1020-1030.
21. Nguyen HT, et al. MicroRNA-7 modulates CD98 expression during intestinal epithelial cell differentiation. J Biol Chem. 2010;285(2):1479-1489.
22. Nakamura E, et al. 4F2 (CD98) heavy chain is associated covalently with an amino acid transporter and controls intracellular trafficking and membrane topology of 4F2 heterodimer. J Biol Chem. 1999;274(5):3009-3016. (Pubitemid 29075388)
23. Dennis G Jr, et al. DAVID: Database for annotation, visualization, and integrated discovery. Genome Biol. 2003;4(5):P3.
24. Hynes RO. Integrins: bidirectional, allosteric signaling machines. Cell. 2002;110(6):673-687. (Pubitemid 35283958)
25. Sartor RB. Mechanisms of disease: pathogenesis of Crohn's disease and ulcerative colitis. Nat Clin Pract Gastroenterol Hepatol. 2006;3(7):390-407. (Pubitemid 44018812)
26. Greten FR, et al. IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell. 2004;118(3):285-296. (Pubitemid 39061110)
27. Grivennikov S, et al. IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer. Cancer Cell. 2009;15(2):103-113.
28. Popivanova BK, et al. Blocking TNF-alpha in mice reduces colorectal carcinogenesis associated with chronic colitis. J Clin Invest. 2008;118(2):560-570. (Pubitemid 351206546)
29. Jones RG, et al. Conditional deletion of beta1 integrins in the intestinal epithelium causes a loss of Hedgehog expression, intestinal hyperplasia, and early postnatal lethality. J Cell Biol. 2006; 175(3):505-514. (Pubitemid 44708073)
30. White DE, et al. Targeted disruption of beta1-integrin in a transgenic mouse model of human breast cancer reveals an essential role in mammary tumor induction. Cancer Cell. 2004;6(2):159-170. (Pubitemid 39485688)
31. McLean GW, Carragher NO, Avizienyte E, Evans J, Brunton VG, Frame MC. The role of focal-adhesion kinase in cancer - a new therapeutic opportunity. Nat Rev Cancer. 2005;5(7):505-515. (Pubitemid 40942827)
32. Henderson NC, et al. CD98hc (SLC3A2) interaction with beta 1 integrins is required for transformation. J Biol Chem. 2004;279(52):54731-54741. (Pubitemid 40053218)
33. Tsumura H, et al. The targeted disruption of the CD98 gene results in embryonic lethality. Biochem Biophys Res Commun. 2003;308(4):847-851. (Pubitemid 36976537)
34. Bresso F, et al. Potential role for the common cystic fibrosis DeltaF508 mutation in Crohn's disease. Inflamm Bowel Dis. 2007;13(5):531-536. (Pubitemid 46799636)
35. D'Amato M, et al. Neuropeptide s receptor 1 gene polymorphism is associated with susceptibility to inflammatory bowel disease. Gastroenterology. 2007;133(3):808-817. (Pubitemid 47381356)
36. Zucchelli M, et al. PepT1 oligopeptide transporter (SLC15A1) gene polymorphism in inflammatory bowel disease. Inflamm Bowel Dis. 2009; 15(10):1562-1569.
37. McGovern DP, et al. Genome-wide association identifies multiple ulcerative colitis susceptibility loci. Nat Genet. 2010;42(4):332-337.
38. Karpinski BA, Yang LH, Cacheris P, Morle GD, Leiden JM. The first intron of the 4F2 heavy-chain gene contains a transcriptional enhancer element that binds multiple nuclear proteins. Mol Cell Biol. 1989;9(6):2588-2597. (Pubitemid 19148135)
39. Pinto D, Robine S, Jaisser F, El Marjou FE, Louvard D. Regulatory sequences of the mouse villin gene that efficiently drive transgenic expression in immature and differentiated epithelial cells of small and large intestines. J Biol Chem. 1999;274(10):6476-6482. (Pubitemid 29111063)
40. Nguyen HT, Dalmasso G, Yan Y, Obertone TS, Sitaraman SV, Merlin D. Ecto-phosphorylation of CD98 regulates cell-cell interactions. PLoS One. 2008;3(12):e3895.